Ticagrelor-d7

CAS: 1265911-55-4

Ref. 3D-QAC91155

Produktinformation

• Name: Ticagrelor-d7

Beschreibung

Ticagrelor-d7 is a chromatographic, spectrometric, and bioequivalence analyte that is used for the treatment of acute coronary syndrome. It inhibits platelet aggregation by blocking the P2Y12 receptor on the platelet membrane. The drug is administered orally, and its pharmacokinetics are linear with a low propensity for accumulation. Ticagrelor-d7 has been shown to be equivalent to ticagrelor in terms of pharmacokinetics and antiplatelet activity in humans.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 529.61 g/mol
• Formel: C₂₃H₂₁D₇F₂N₆O₄S
• Reinheit: Min. 95%